BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21513569)

  • 21. Molecular monitoring of dihydrofolatereductase (dhfr) and dihydropteroatesynthetase (dhps) associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates of Palawan, Philippines.
    Bareng AP; Espino FE; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2018 Apr; 180():81-87. PubMed ID: 29352991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
    Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of mutations in the antifolates resistance-associated genes (dhfr and dhps) in Plasmodium vivax parasites from Eastern and Central Sudan.
    Pirahmadi S; Talha BA; Nour BY; Zakeri S
    Infect Genet Evol; 2014 Aug; 26():153-9. PubMed ID: 24861816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.
    Nzila AM; Mberu EK; Sulo J; Dayo H; Winstanley PA; Sibley CH; Watkins WM
    Antimicrob Agents Chemother; 2000 Apr; 44(4):991-6. PubMed ID: 10722502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.
    McCollum AM; Schneider KA; Griffing SM; Zhou Z; Kariuki S; Ter-Kuile F; Shi YP; Slutsker L; Lal AA; Udhayakumar V; Escalante AA
    Malar J; 2012 Mar; 11():77. PubMed ID: 22439637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
    Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
    J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia.
    Asih PB; Marantina SS; Nababan R; Lobo NF; Rozi IE; Sumarto W; Dewi RM; Tuti S; Taufik AS; Mulyanto ; Sauerwein RW; Syafruddin D
    Malar J; 2015 Sep; 14():365. PubMed ID: 26395428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East.
    Zakeri S; Motmaen SR; Afsharpad M; Djadid ND
    Malar J; 2009 Jan; 8():20. PubMed ID: 19175936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent.
    Kaur S; Prajapati SK; Kalyanaraman K; Mohmmed A; Joshi H; Chauhan VS
    Acta Trop; 2006 Feb; 97(2):174-80. PubMed ID: 16310156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites.
    Chaturvedi R; Chhibber-Goel J; Verma I; Gopinathan S; Parvez S; Sharma A
    Int J Parasitol; 2021 Jun; 51(7):505-525. PubMed ID: 33775670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand.
    Rungsihirunrat K; Sibley CH; Mungthin M; Na-Bangchang K
    Am J Trop Med Hyg; 2008 Mar; 78(3):462-7. PubMed ID: 18337344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study.
    Biswas S; Escalante A; Chaiyaroj S; Angkasekwinai P; Lal AA
    Trop Med Int Health; 2000 Oct; 5(10):737-43. PubMed ID: 11044269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress of researches on genes associated with sulfadoxine-pyrimethamine resistance in
    Qi-Cheng Z; Feng L
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2019 Apr; 31(3):346-348. PubMed ID: 31544425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
    Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
    J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy.
    Aubouy A; Jafari S; Huart V; Migot-Nabias F; Mayombo J; Durand R; Bakary M; Le Bras J; Deloron P
    J Antimicrob Chemother; 2003 Jul; 52(1):43-9. PubMed ID: 12805261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania.
    Pearce RJ; Drakeley C; Chandramohan D; Mosha F; Roper C
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1347-54. PubMed ID: 12654669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of dihydrofolate reductase and dihydropteroate synthetase genotypes that confer resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum in Haiti.
    Carter TE; Warner M; Mulligan CJ; Existe A; Victor YS; Memnon G; Boncy J; Oscar R; Fukuda MM; Okech BA
    Malar J; 2012 Aug; 11():275. PubMed ID: 22889367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.